FibroBiologics (FBLG) Institutional Ownership

During the previous two years, 26 institutional investors and hedge funds held shares of FibroBiologics. The most heavily invested institutionals were Fund Evaluation Group LLC ($5.27M), Geode Capital Management LLC ($1.85M), State Street Corp ($1.47M), Transform Wealth LLC ($668K), Bank of New York Mellon Corp ($342K), Cascade Financial Partners LLC ($234K), and Charles Schwab Investment Management Inc. ($215K).Learn more on FBLG's institutional investors.

Of the 25 institutional investors that purchased FibroBiologics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fund Evaluation Group LLC ($1.06M), Cascade Financial Partners LLC ($315.06K), Geode Capital Management LLC ($284.05K), Transform Wealth LLC ($133.89K), State Street Corp ($99.79K), Bank of New York Mellon Corp ($68.56K), and Barclays PLC ($62.66K).

Institutional investors have bought a total of 2,504,651 shares in the last 24 months. This purchase volume represents approximately $10.68M in transactions.

The following institutional investors have sold FibroBiologics stock in the last 24 months: Cascade Financial Partners LLC ($42.52K), and Marshall Wace LLP ($35.32K).

Institutional investors have sold a total of 77,843 shares in the last 24 months. This volume of shares sold represents approximately $236.53K in transactions.